| Title |
Pregnancy Outcomes among Women Receiving rVSVΔ-ZEBOV-GP Ebola Vaccine during the Sierra Leone Trial to Introduce a Vaccine against Ebola - Volume 26, Number 3—March 2020 - Emerging Infectious Diseases journal - CDC
|
|---|---|
| Published in |
Emerging Infectious Diseases, March 2020
|
| DOI | 10.3201/eid2603.191018 |
| Pubmed ID | |
| Authors |
Jennifer K. Legardy-Williams, Rosalind J. Carter, Susan T. Goldstein, Olamide D. Jarrett, Elena Szefer, Augustin E. Fombah, Sarah C. Tinker, Mohamed Samai, Barbara E. Mahon |
X Demographics
The data shown below were collected from the profiles of 41 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 7 | 17% |
| Japan | 6 | 15% |
| Rwanda | 2 | 5% |
| United Kingdom | 1 | 2% |
| Netherlands | 1 | 2% |
| Argentina | 1 | 2% |
| Australia | 1 | 2% |
| Italy | 1 | 2% |
| Belgium | 1 | 2% |
| Other | 0 | 0% |
| Unknown | 20 | 49% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 33 | 80% |
| Scientists | 5 | 12% |
| Practitioners (doctors, other healthcare professionals) | 2 | 5% |
| Science communicators (journalists, bloggers, editors) | 1 | 2% |
Mendeley readers
The data shown below were compiled from readership statistics for 70 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 70 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 8 | 11% |
| Student > Bachelor | 7 | 10% |
| Student > Ph. D. Student | 6 | 9% |
| Researcher | 4 | 6% |
| Student > Doctoral Student | 2 | 3% |
| Other | 8 | 11% |
| Unknown | 35 | 50% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 14 | 20% |
| Nursing and Health Professions | 9 | 13% |
| Biochemistry, Genetics and Molecular Biology | 3 | 4% |
| Unspecified | 2 | 3% |
| Psychology | 2 | 3% |
| Other | 5 | 7% |
| Unknown | 35 | 50% |
Attention Score in Context
This research output has an Altmetric Attention Score of 40. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 August 2021.
All research outputs
#1,042,691
of 25,651,057 outputs
Outputs from Emerging Infectious Diseases
#1,189
of 9,775 outputs
Outputs of similar age
#27,822
of 405,974 outputs
Outputs of similar age from Emerging Infectious Diseases
#24
of 167 outputs
Altmetric has tracked 25,651,057 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 9,775 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 46.1. This one has done well, scoring higher than 87% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 405,974 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 167 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 85% of its contemporaries.